Navigation Links
New Stop Smoking Aid Offers Unique Teeth Whitening Benefit

Teeth Discoloration a Top Motivator When it Comes to Encouraging Smokers to

Quit, New Survey Finds

PITTSBURGH, Pa., Nov. 10 /PRNewswire/ -- Smokers now have a new motivation to quit, a first of its kind stop-smoking gum with a whitening benefit. Nicorette(R) White Ice Mint is the first stop-smoking aid with a whitening benefit that not only helps with tough cravings and withdrawal symptoms, but also helps whiten teeth.(1) A new survey found half (49 percent) of smokers surveyed say the yellowing of their teeth strongly contributes to their decision to quit smoking.(2) Further, younger smokers (68 percent) under the age of 35 are especially concerned about the effects of smoking on their teeth, and more of them (82 percent) want to quit smoking because of it.(2)

Experts believe this new stop-smoking product is important because it provides smokers with a new option to quit smoking and the unique whitening may be an extra push to motivate smokers to initiate a quit attempt. In fact, the survey shows that 72 percent of people believe a quit-smoking product with teeth whitening benefits will encourage them so they can quit for good.(2)

"What is interesting about this survey is that while smokers are well-aware of the health risks, appealing to their vanity may actually help to push them into action and to decide to quit," said Dr. Catrise Austin, founder and director of VIP Smiles in New York City and 'dentist to the stars.' "As a cosmetic dentist, I've seen firsthand the impact smoking has on the appearance and health of a person's teeth. I'm thrilled to have a new option to discuss with my patients. Nicorette White Ice Mint meets their unique needs by controlling cravings and whitening their teeth."

According to the survey, 42 percent of smokers are still trying to quit on their own without help.(2) Yet, smokers are twice as likely to be successful if they use therapeutic nicotine rather than quitting cold turkey.(1) Nicorette White Ice Mint is specifically designed to relieve withdraw symptoms by safely and gradually reducing dependence on nicotine.(1) Nicorette White Ice Mint provides smokers with the help they need to end their smoking addiction, and the product's whitening benefit can strengthen motivation.(2)

"Smoking is one of the most difficult addictions to break, and every smoker is different -- in terms of their habits, triggers and what motivates them to quit," said Saul Shiffman, Ph.D., lead researcher and professor in the departments of psychology and pharmaceutical science at the University of Pittsburgh. "Anything that encourages a smoker to quit is a positive thing, but they need help to quit successfully. Nicorette White Ice Mint is a new, safe, effective option that helps smokers overcome difficult cravings and quit for good."

Nicorette White Ice Mint is readily available over the counter without a doctor's prescription at more than 35,000 retail outlets, and can help reduce withdrawal symptoms commonly associated with quitting smoking.(3) Smokers interested in quitting can visit for more information about new Nicorette White Ice Mint.

Over-the-counter therapeutic nicotine products like Nicorette gum, NicoDerm CQ patch, and Commit lozenge are first-line treatments for smoking cessation and are thoroughly researched, well-understood and highly accessible stop smoking therapies.(4) Unfortunately, the majority of smokers try to quit with no assistance at all and only 3-5 percent of smokers who quit "cold turkey" are successful long-term.(5)

About Nicorette

Nicorette is a stop-smoking aid which provides fast, safe, controlled doses of nicotine to ease withdrawal from cigarettes. Convenient to carry and use, Nicorette allows smokers to control how much nicotine they use, and gives them the added flexibility of chewing an additional piece within the hour to treat strong or frequent cravings. Nicorette is sugar-free and available in strengths of 2mg (for smokers of less than 25 cigarettes each day) and 4mg (for smokers of 25 or more cigarettes each day) and also is available in exciting flavors such as Fresh Mint, Fruit Chill, and Cinnamon Surge.

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R) and NicoDerm(R)CQ(R), and Commit(R), as well as many medicine cabinet staples -- alli(R), Aquafresh(R), Sensodyne(R), and TUMS(R) -- which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit:

(1) Silagy C, Stead LF, et. al. Nicotine replacement therapy for smoking

cessation. Cochrane Database of Systematic Reviews 1996, Issue 3. Art.

No.: CD000146. DOI: 10.1002/14651858.CD000146.pub3. Available at:

(2) Survey of 327 smokers, Richard Day Research. September 2008.

(3) GSK Data on file.

(4) Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and

Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD:

U.S. Department of Health and Human Services. Public Health Service.

May 2008.

(5) Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term

abstinence among untreated smokers. 2004 Addiction, 99, 29-38.

Contacts: Mark Polisky, GolinHarris


Jennifer May, GlaxoSmithKline

Consumer Healthcare


SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Current Economic Situation Prompts Increased Smoking, Delay in Quit Attempts, Middle and Low-Income Americans Hit Hardest
2. Smoking Coupled With Obesity Raises Death Risk
3. Study finds racial disparities increasing for cancers unrelated to smoking
4. Moms Smoking Linked to Increased Risk of Birth Defects
5. Moms smoking linked to increased risk of birth defects
6. Miss America 2008 Kirsten Haglund Embarks on National Tour to Present Her New Mission: To Help People Quit Smoking
7. Anti-Smoking Web Site Helps Parents Plug Into Prevention
8. Physicians lack smoking cessation training
9. Doctors Lack Smoking Cessation Training
10. Hospital-based smoking cessation program after heart attack adds to success
11. New Report: Ballot Measure 3 Will Reduce Smoking, Save Lives and Save Money in North Dakota
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology: